FierceBiotechOriginal article
{"a":[{"_":"CytoDyn’s leronlimab reaffirms HIV potential after combo treatment eradicates virus in infant macaques","$":{"href":"/biotech/cytodyns-leronlimab-aims-comeback-it-eradicates-hiv-infant-macaques-combination-hiv","hreflang":"en"}}]}
Data ReadoutpositiveleronlimabPositive
AI Analysis
Summary
CytoDyn's leronlimab demonstrated viral eradication in infant macaques when used as a combination treatment, providing renewed hope for the CCR5-targeting antibody despite previous setbacks in HIV approval efforts.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Leronlimab in combination treatment eradicated HIV virus in infant macaques
Importance:5/10
Sentiment:
0.70
HIVleronlimabCCR5-targeting antibodypreclinicalprimate study
Related Companies
Read the original article
Published by FierceBiotech on August 11, 2026 7:52 PM